The brief

Analyst view

• Series A of $100M in July 2025 led by Thrive Capital and Greenoaks.
• Uses focused ultrasound to stimulate brain circuits without surgery.

Technical approach

As reported

Platform

Focused ultrasound brain interface

Integrated hardware and software delivering focused ultrasound through skull to deep brain structures with millimeter precision.

Safety

Non-invasive procedure

Avoids open surgery and implants, aiming to make deep brain stimulation accessible to more patients by eliminating infection risk and surgical recovery.